ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 609,15
-0,69%
Dow Jones
39 127,80
0,04%
DAX
18 155,24
-0,04%
Brent Oil
84,47
0,34%
Bitcoin
60 869,05
-1,52%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Mural Oncology PLC (MURA)

  7. Mural Oncology PLC (MURA) Actualités

MURA

Mural Oncology (MURA)

Mural Oncology PLC
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:MURA
DateHeureSourceTitreSymboleSociété
05/06/202422h15GlobeNewswire Inc.Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor ConferenceNASDAQ:MURAMural Oncology PLC
04/06/202422h00GlobeNewswire Inc.Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:MURAMural Oncology PLC
23/05/202423h00GlobeNewswire Inc.Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual MeetingNASDAQ:MURAMural Oncology PLC
14/05/202413h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MURAMural Oncology PLC
14/05/202413h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MURAMural Oncology PLC
14/05/202413h00GlobeNewswire Inc.Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:MURAMural Oncology PLC
24/04/202422h00GlobeNewswire Inc.Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:MURAMural Oncology PLC
09/04/202422h00GlobeNewswire Inc.Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual MeetingNASDAQ:MURAMural Oncology PLC
26/03/202412h00GlobeNewswire Inc.Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business UpdateNASDAQ:MURAMural Oncology PLC
05/03/202422h35GlobeNewswire Inc.Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:MURAMural Oncology PLC
27/02/202413h00GlobeNewswire Inc.Mural Oncology to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:MURAMural Oncology PLC
08/01/202413h00GlobeNewswire Inc.Mural Oncology Announces Enhancements to Late-Stage Clinical TrialsNASDAQ:MURAMural Oncology PLC
15/11/202313h00GlobeNewswire Inc.Mural Oncology Launches to Advance Pipeline of Novel Engineered Cytokine ImmunotherapiesNASDAQ:MURAMural Oncology PLC
 Showing the most relevant articles for your search:NASDAQ:MURA

Dernières Valeurs Consultées

USOTC
ONTRF
Blackrock Oil (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés